# K153053: Traxcess Pro 14 Guidewire

- Pathway: 510(k) (Special)
- Applicant: MicroVention, Inc.
- Decided: Dec 29, 2015 after 70 days
- Product code: MOF (Guide, Wire, Catheter, Neurovasculature)
- Device class: 2
- Regulation: 21 CFR 870.1330
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K953533 (1995). 7 ancestors in all.
4 later devices descend from it; 2 cite it directly.
0 of 12 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K133725: Traxcess 14 Guidewire, MicroVention, Inc. (2014) Summary page 4.

## Most influential descendants
- K161803: Traxcess .007 Mini Guidewire (2016), 2 descendants of its own
- K201487: Traxcess 7 Mini Guidewire (2020), 0 descendants of its own
- K200547: Traxcess 14 SELECT Guidewire (2020), 0 descendants of its own
- K163154: Traxcess 7 Mini XSoft Guidewire (2016), 0 descendants of its own

## Indications for use
The Traxcess® Pro 14 Guidewire is intended for general intravascular use, including the neuro and peripheral vasculature. The guidewire can be steered to facilitate the selective placement of diagnostic or therapeutic catheters. This device is not intended for use in coronary arteries.

Source page: https://510kreport.com/device/K153053
Methodology: https://510kreport.com/methodology